Sleep Apnea Treatment After Stroke (SATS)
Treatment of Obstructive Sleep Apnea After Stroke
Sponsor: University of Michigan
Terminated
Poor recruitment. Funding expired.
Other terminated trials from University of Michigan
Other Obstructive Sleep Apnea trials with similar outcome
Listed as NCT00282815, this PHASE2 trial focuses on Obstructive Sleep Apnea and Stroke and remains terminated or withdrawn. Sponsored by University of Michigan, it has been updated 9 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
Sep 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Michigan
For direct contact, visit the study record on ClinicalTrials.gov .